Interferon-based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C

Interferon-based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C

Background. We compared mortality and complications of chronic hepatitis C between treated and untreated Mexican patients after long-term follow-up. We used a time-to-event analysis and identified the prognostic factors.Material and methods. Seventy-four patients with chronic hepatitis C were studie...

Full description

Bibliographic Details
Main Authors: Roberto F. Martínez-Macías, Paula Cordero-Pérez, Omar A. Juárez-Rodríguez, Carlos Y. Chen-López, Francisco M. Martínez-Carrillo, Gabriela Alarcón-Galván, Roberto Mercado-Hernández, Linda E. Muñoz-Espinosa, MD, PhD.
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Annals of Hepatology
Subjects:
Hepatic disease
Longitudinal follow-up
Diabetes mellitus
Hepatic decompensation
Hispanics
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119307999

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119307999

Similar Items